Compare ACN & WELL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACN | WELL |
|---|---|---|
| Founded | 1989 | 1970 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Real Estate Investment Trusts |
| Sector | Consumer Discretionary | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 129.2B | 150.1B |
| IPO Year | 2015 | 1994 |
| Metric | ACN | WELL |
|---|---|---|
| Price | $171.97 | $206.65 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 13 |
| Target Price | ★ $270.81 | $224.38 |
| AVG Volume (30 Days) | ★ 5.1M | 2.9M |
| Earning Date | 03-19-2026 | 04-28-2026 |
| Dividend Yield | ★ 3.62% | 1.40% |
| EPS Growth | ★ 6.21 | N/A |
| EPS | ★ 6.47 | 1.02 |
| Revenue | ★ $69,672,977,000.00 | $10,838,034,000.00 |
| Revenue This Year | $7.44 | $28.56 |
| Revenue Next Year | $5.26 | $6.97 |
| P/E Ratio | ★ $26.96 | $195.97 |
| Revenue Growth | 7.36 | ★ 35.63 |
| 52 Week Low | $155.82 | $148.70 |
| 52 Week High | $321.77 | $221.68 |
| Indicator | ACN | WELL |
|---|---|---|
| Relative Strength Index (RSI) | 42.94 | 48.30 |
| Support Level | $155.82 | $196.35 |
| Resistance Level | $184.35 | $214.92 |
| Average True Range (ATR) | 7.00 | 6.16 |
| MACD | -0.18 | -1.03 |
| Stochastic Oscillator | 6.76 | 47.22 |
Accenture is a leading IT services firm that provides consulting, system integration, and business process outsourcing to enterprises around the world. Customers of Accenture come from a variety of sectors, including communications, media and technology, financial services, health and public services, consumer products, and resources. Accenture is the world's largest professional services company by headcount with around 800,000 employees in over 120 countries.
Welltower owns a diversified healthcare portfolio of 2,800 in-place properties spread across the senior housing, medical office, and skilled nursing/postacute care sectors. The portfolio includes over 900 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to that of the United States.